Wnt Pathway

The Wnt pathway is a conserved signaling pathway in metazoan animals. The name Wnt is the resultant of a fusion of the name of the Drosophila segment polarity gene "wingless" and the name of the vertebrate homolog,  integrated or int-1 [4]. Wnt proteins constitute a large family of glycoproteins that are secreted and serve crucial roles in various biological processes such as embryonic development, cell differentiation, cell motility, cell proliferation, and maintenance of adult tissue equilibrium. The Wnt signaling pathway encompasses multiple mechanisms, including the β-Catenin-dependent TCF/LEF transcription pathway, or the canonical pathway, as well as two well-characterized β-Catenin-independent pathways known as the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway, or the non-canonical pathway.

Wnt Signaling Pathway Antibody Panel

Biomarker APC BETA CATENIN DISHEVELLED 2 LEF1 RSPO1 RSPO3 SENP2 SOX17 TLE 1
Catalog-No. TA803655S

30 ul

APC mouse monoclonal antibody, clone OTI2B8 (formerly 2B8)

UM570015

30 ul

Beta-Catenin (CTNNB1) mouse monoclonal antibody, clone UMAB15

TA806791S

30 ul

DVL2 mouse monoclonal antibody, clone OTI2D11 (formerly 2D11)

TA812988S

30 ul

LEF1 mouse monoclonal antibody,clone OTI10A7

TA804766S

30 ul

RSPO1 mouse monoclonal antibody, clone OTI1C3 (formerly 1C3)

TA804633S

30 ul

RSPO3 mouse monoclonal antibody, clone OTI3D5 (formerly 3D5)

TA504817S

30 ul

SENP2 mouse monoclonal antibody, clone OTI1H2 (formerly 1H2)

TA500096S

30 ul

Sox17 mouse monoclonal antibody, clone OTI2G8 (formerly 2G8)

TA800294S

30 ul

TLE1 mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)

Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
select all

Canonical Wnt Pathway

In the β-Catenin-dependent signaling pathway, Wnt proteins interact with Frizzled and LRP-5/6 receptors, initiating a cascade of events. This interaction activates dishevelled, which then recruits the Axin protein complex (consisting of Axin, APC, CK1, and GSK-3 β) to the receptor. Within the Axin complex, two kinases, Glycogen Synthase Kinase-3 β (GSK-3 β) and Casein Kinase 1 (CK1), phosphorylate LRP-5/6. Subsequently, the entire protein complex is internalized into endosomes, leading to the formation of multivesicular bodies. These bodies sequester GSK-3 β, hindering its ability to phosphorylate newly synthesized β-Catenin. As a result, unphosphorylated β-Catenin accumulates and translocates into the nucleus, where it associates with TCF/LEF family transcription factors and co-activators like Bcl-9 and Pygopus (Pygo). This association induces the expression of Wnt target genes. In the absence of Wnt, cytoplasmic β-Catenin undergoes phosphorylation by CK1 and GSK-3 β in a complex known as the β-Catenin destruction complex (Axin, APC, CK1, GSK-3 β). These phosphorylation events create a docking site for β-TrCP, an E3 ubiquitin ligase that promotes the ubiquitination and subsequent degradation of β-Catenin via the proteasome.

Download here

Canonical Wnt Pathway Activation and Inhibition
Fig 1: Canonical WNT Pathway Activation and Inhibition [1]

Non-Canonical Wnt Pathway

Besides the β-Catenin-dependent pathway, there are two well-characterized β-Catenin-independent Wnt signaling pathways: the PCP pathway and the Wnt/Ca2+ pathway. Both pathways act as inhibitors of Wnt-β-Catenin-dependent signaling. In the PCP pathway, Wnt binding to Frizzled receptors, along with co-receptors such as ROR1/2, Ryk, or PTK7, triggers receptor internalization and activates downstream components like Rho and Rac GTPases, Rho-Kinase (ROCK), and c-Jun N-terminal kinase (JNK). Together, these components regulate cell motility and tissue polarity.

On the other hand, the Wnt-Ca2+ pathway is initiated by Frizzled receptors engaging in classical G protein-coupled signaling. Frizzled-G protein signaling activates Phospholipase C-β (PLC-β), which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into 1,2-diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3). DAG and IP3 production leads to the activation of Protein Kinase C (PKC), Calcium/Calmodulin-dependent Protein Kinase type II (CaMKII)-TGF-β-activated kinase 1 (TAK1)-Nemo-like kinase (NLK) pathway, and Calcineurin phosphatase. These activated components collectively regulate cell fate and cell migration by modulating specific genes.

Download here

Non-Canonical Wnt Pathway
Fig 2. Non-Canonical WNT Pathway [2,3]

Wnt Target Gene Antibody Panel

Biomarker C-JUN C-MYC FRA1 LGR5 MMP7 PPAR DELTA
Catalog-No. UM870005

30 ul

JUN mouse monoclonal antibody,clone UMAB49

TA500002S

30 ul

c-Myc (c-Myc ) mouse monoclonal antibody, clone OTI1A6 (formerly 1A6)

TA500624S

30 ul

Anti-FOSL1 (FRA1) mouse monoclonal antibody, clone OTI12F9 (formerly 12F9)

UM870104

30 ul

LGR5 mouse monoclonal antibody,clone UMAB212

UM870061

30 ul

MMP7 mouse monoclonal antibody,clone UMAB168

TA811238S

30 ul

PPARD mouse monoclonal antibody,clone OTI4D10

Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
select all

The Wnt/β-catenin pathway plays critical roles in embryonic development and adult tissue homeostasis. The dysregulation of Wnt/β-catenin signaling often leads to many serious diseases, including cancer and non-cancer diseases. The multifaceted significance of studying the Wnt pathway becomes apparent when considering its impact on development, stem cell biology, cancer research, tissue homeostasis, neurobiology, drug discovery, and evolutionary biology. Through in-depth investigations, researchers can unravel the intricate mechanisms of the Wnt pathway, leading to improved diagnostics, targeted therapies, regenerative medicine approaches, and a deeper understanding of fundamental biological processes.

Tools to Study Wnt Pathway Markers

Antibodies Proteins Plasmids Lentivirus AAV Custom Solutions

References

  1. Liu, Jiaqi, et al. "Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities." Signal transduction and targeted therapy 7.1 (2022): 3.
  2. Patel, Sonal, et al. "Wnt signaling and its significance within the tumor microenvironment: novel therapeutic insights." Frontiers in immunology 10 (2019): 2872.
  3. Pai, Sachin Gopalkrishna, et al. "Wnt/beta-catenin pathway: modulating anticancer immune response." Journal of hematology & oncology 10 (2017): 1-12.
  4. Zhang, Ya, and Xin Wang. "Targeting the Wnt/β-catenin signaling pathway in cancer." Journal of hematology & oncology 13 (2020): 1-16.